PELOSI, NANCY BUYNVDA$500K–$1M·TUBERVILLE, TOMMY BUYMSFT$50K–$100K·CRENSHAW, DAN SELLXOM$15K–$50K·PELOSI, NANCY BUYNVDA$500K–$1M·TUBERVILLE, TOMMY BUYMSFT$50K–$100K·CRENSHAW, DAN SELLXOM$15K–$50K·
K-STREET TRACKER

FOLLOW THE MONEY INTO THE SWAMP

Every federal lobbying filing tagged with a public-company ticker — who is spending, which firms they hire, and which members trade right around the filing.

Filings tracked
19,882
thru 2026-05-08
Total reported $
$2.7B
disclosed lobbying
Distinct clients
2,220
paying companies
Tickers targeted
1,207
public companies

💸 Top Spending Clients

🎯 Top Lobbied Tickers

#TickerFilingsTotal $
1META
Meta Platforms Inc.
129$50.2M
2PFE
Pfizer Inc.
87$48.6M
3GM
General Motors Company
103$48.4M
4V
Visa Inc.
46$37.7M
5AMZN
Amazon.com Inc.
80$35.3M
6LMT
Lockheed Martin Corporation
88$29.4M
7FDX
FedEx Corporation
82$28.3M
8LLY
Eli Lilly and Company
83$28.1M
9AMGN
Amgen Inc.
95$28.0M
10MRK
Merck & Co. Inc.
92$27.5M
11AAPL
Apple Inc.
64$26.8M
12GOOGL
Alphabet Inc. Class A
123$26.6M
13MO164$26.2M
14SO
Southern Company
108$26.1M
15UNH
UnitedHealth Group Inc.
67$23.9M
16VZ
Verizon Communications Inc.
116$23.8M
17TMUS159$22.7M
18CHTR137$22.6M
19GD
General Dynamics Corporation
127$22.5M
20T
AT&T Inc.
134$21.6M
21ORCL
Oracle Corporation
132$20.6M
22CMCSA
Comcast Corporation
141$20.4M
23CI
The Cigna Group
64$19.9M
24OXY
Occidental Petroleum Corporation
36$19.9M
25MSFT
Microsoft Corporation
122$19.2M

🆕 Filtered Filings · SANOFI US SERVICES INC (FORMERLY KNOWN AS GENZYME CORPORATION)

clear filters
DateTickerClientRegistrantAmountIssue
2026-04-20SNYSANOFI US SERVICES INC (FORMERLY KNOWN AS GENZYME CORPORATION)TARPLIN, DOWNS & YOUNG, LLC$60KIRA, transparency, vaccines, coverage and access IRA, supply chain integrity, drug pricing in federal programs, orphan drugs, newborn screening, expanded access, transparency, drug shortages, drug pricing, insulin, diabetes screening, COPD federal budget issues
2026-01-20SNYSANOFI US SERVICES INC (FORMERLY KNOWN AS GENZYME CORPORATION)TARPLIN, DOWNS & YOUNG, LLC$60KIRA, transparency, vaccines, coverage and access IRA, supply chain integrity, drug pricing in federal programs, orphan drugs, newborn screening, expanded access, transparency, drug shortages, drug pricing, insulin, diabetes screening, COPD federal budget issues
2025-10-16SNYSANOFI US SERVICES INC (FORMERLY KNOWN AS GENZYME CORPORATION)TARPLIN, DOWNS & YOUNG, LLC$60KIRA, transparency, vaccines, coverage and access IRA, supply chain integrity, drug pricing in federal programs, orphan drugs, newborn screening, expanded access, transparency, drug shortages, drug pricing, insulin, diabetes screening, COPD federal budget issues
2025-07-17SNYSANOFI US SERVICES INC (FORMERLY KNOWN AS GENZYME CORPORATION)TARPLIN, DOWNS & YOUNG, LLC$60Kfederal budget issues IRA, transparency, vaccines, coverage and access IRA, supply chain integrity, 340B, orphan drugs, newborn screening, expanded access, transparency, drug shortages, drug pricing, insulin, diabetes screening, COPD
2025-04-21SNYSANOFI US SERVICES INC (FORMERLY KNOWN AS GENZYME CORPORATION)TARPLIN, DOWNS & YOUNG, LLC$60KIRA, transparency, vaccines, coverage and access IRA, supply chain integrity, 340B, orphan drugs, newborn screening, expanded access, transparency, drug shortages, drug pricing, insulin, diabetes screening, COPD federal budget issues orphan drug tax credit, vaccine policy
2025-01-21SNYSANOFI US SERVICES INC (FORMERLY KNOWN AS GENZYME CORPORATION)TARPLIN, DOWNS & YOUNG, LLC$60KIRA implementation, transparency, vaccines, coverage and access IRA implementation, supply chain integrity, 340B, orphan drugs, newborn screening, expanded access, transparency, drug shortages, drug pricing, insulin, diabetes screening, COPD federal budget issues orphan drug tax credit, vaccine policy